Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NAM Group of Industries is a WHO-GMP certified pharmaceutical manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and intermediates for both human and veterinary medicine. Based in India, the company operates state-of-the-art facilities that produce a wide range of high-quality chemical substances, including anticonvulsants, analgesics, and antibiotics. Their product portfolio features well-known compounds such as Pregabalin, Lidocaine, and Guaifenesin, catering to global pharmaceutical needs. With a strong focus on research and development and stringent quality control, NAM Group serves as a critical supplier in the healthcare supply chain, ensuring the availability of essential medicinal components across international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NAM.